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ABSTRACT 
A series of 15 (E)-N-benzylidenebenzohydrazide analogues were evaluated for their antimicrobial activities 
against eleven pathogenic and food-borne microbes, namely, S. aureus (G+), L. monocytogenes (G+), B. subtilis 
(G+), K. pneumonia (G), C. sakazakii (G), C. freundii (G), S. enterica (G), S. enteritidis (G), E. coli (G), Y. 
pestis (G), and P. aeruginosa (G). Most of the compounds exhibited selective activity against some Gram-
negative bacterial strains. Of the compounds tested (3a-o), 3b and 3g were most active against C. freundii (MIC 
= ~19 µg mL-1). Whereas, compounds 3d, 3i, 3k and 3n exhibited MIC values ranging from 37.5 to 75 g mL1 
against C. freundii, and compounds 3e, 3l and 3n had MIC values of ~75 g mL1 against K. pneumonia. Quanti-
tative structure-antibacterial activity relationships were studied using physicochemical parameters and a good 
correlation was found between calculated octanol-water partition coefficients (clogP; a lipophilic parameter) and 
antibacterial activities. In silico screening was also performed by docking high (3b and 3g) and low (3n) activity 
compounds on the active site of E. coli FabH receptor, which is an important therapeutic target. The findings of 
these in silico screening studies provide a theoretical basis for the design and synthesis of novel benzylideneben-
zohydrazide analogues that inhibit bacterial FabH. 
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INTRODUCTION 
Isoniazid (isonicotinylhydrazide; INH) 
(Figure 1A) is a front-line antimycobacterial 
that is usually used to treat tuberculosis. INH 
exerts its activity via a bacterial catalase-
peroxidase (KatG) (Suarez et al., 2009) by 
forming isonicotinic acyl-NADH complex, 
which interacts firmly to enoyl-acyl carrier 
protein reductase (InhA), and thus, inhibits 
the synthesis of mycolic acid, and mycobac-
terial cell growth. A hydrazone Schiff base 
analogue of INH (Figure 1A) has been re-
ported to have antimycobacterial activity 
against INH resistant M. tuberculosis strains 
and to exhibit lower toxicity than INH (Sah 
and Peoples, 1954; Bavin et al., 1954) and 
nifuroxazide – a commercial hydrazide-
hydrazone Schiff base antibiotic used to treat 
colitis and diarrhea. Another analogue of ni-
furoxazide was found to show antimicrobial 
activity comparable to that of ceftriaxone 
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(Rollas et al., 2002). Currently, bacterial re-
sistance to existing drugs, such as, β-lactam 
antibiotics, macrolides, quinolones, and van-
comycin, is considered one of the most im-
portant health concerns (Cassell and 
Mekalanos, 2001), and thus, sustained re-
search efforts are being made to identify new 
drugs with wide therapeutic windows, broad 
spectrum activities, and novel modes of ac-
tion. A literature survey revealed that syn-
thetics and natural products containing the 
hydrazone Schiff base or Schiff base motif 
exert their antibiotic activities by inhibiting 
fatty acid biosynthesis (FAB) (Cheng et al., 
2009; Shi et al., 2010; Song et al., 2014a). In 
prokaryotic organisms, FAB is crucially re-
quired for cell viability and growth (Song et 
al., 2014b). β-Ketoacyl-acyl carrier protein 
(ACP) synthase III (FabH or KAS III) plays 
an important role in bacterial FAB 
(Khandekar et al., 2003) and is considered an 
essential functional enzyme in the bacterial 
FAB system. Bacterial FabH has no homo-
log in man, and thus, is an attractive target 
for the design of new antibiotics (Lee et al., 
2009 and 2012). The structures of several re-
ported antibacterial FabH inhibitors that pos-
sess a Schiff base or hydrazone Schiff base 
motif are shown in Figure 1B, and interest-
ingly, these structural motifs are also found 
in many bioactive compounds.  
Hydrazone Schiff bases possess 
-CONHN=CH- moiety and they are widely 
exploited to syntheses of various biologically 
active molecules. In addition, they have 
shown wide-ranging bioactivities. For exam-
ple, antimicrobial (Vijesh et al., 2013), anti-
cancer (Dandawate et al., 2012), anti-
mycobacterial (Mahajan et al., 2011), anti-
convulsant (Kulandasamy et al., 2009), anti-
inflammatory (Rajitha et al., 2011), analgesic 
(Kümmerle et al., 2009), anti-hypertensive 
(Leal et al., 2012), anti-platelet (Mashayekhi 
et al., 2013), and anti-protozoal activities 
(Carvalho et al., 2012). Hydrazones are also 
used as herbicides, insecticides, nemato-
cides, rodenticides, plant growth regulators, 
and housefly sterilants (Akelah et al., 1993; 
Mohan et al., 1988). Hydrazone Schiff bases 
are versatile polydentate chelating agents and 
form a variety of complexes with various 
transition and inner transition metals with 
different bioactivities and practical applica-
tions (Gad et al., 2000; Zhong et al., 2007; 
Fan et al., 2010; Juliano et al., 2010). These 
wide-ranging biochemical activities and uses 
of hydrazone Schiff bases and their com-
plexes have attracted considerable research 
attention. 
 
Figure 1: Structures of (A) key molecules and (B) some reported potential FabH inhibitors possessing 
a hydrazone Schiff base or Schiff base motif 
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During our continued studies (Alam et al., 
2013, 2014, 2015) on novel bioactive com-
pounds, we evaluated the antimicrobial ac-
tivities of a series of (E)-N'-benzylidene-
benzohydrazide analogues (3a-o) exhibiting 
structural similarities with INH and nifurox-
azide. In a previous study, we described the 
synthesis and cytotoxic and antioxidant ac-
tivities of a series of fifteen (E)-N'-
benzylidenebenzohydrazide analogues 
(Alam and Lee, 2016). Here, we report the in 
vitro antibacterial activities of these fifteen 
(E)-N'-benzylidenebenzohydrazide ana-
logues (3a-o) against 11 pathogenic and 
food-borne bacterial strains, that is, three 
Gram-positive (Staphylococcus aureus, Lis-
teria monocytogenes, and Bacillus subtilis), 
and eight Gram-negative bacterial strains 
(Klebsiella pneumoniae, Cronobacter sa-
kazakii, Citrobacter freundii, Salmonella en-
terica, Salmonella enteritidis, E. coli, Yer-
sinia pestis, and Pseudomonas aeruginosa). 
In addition, physicochemical characteristics 
of the synthesized compounds were used to 
access quantitative structure-antibacterial ac-
tivity relationships (Q-SAR). Finally, in sili-
co screening was performed using docking 
simulations using the X-ray crystallography 
determined structure of E. coli FabH to in-
vestigate the binding affinities and interac-
tion modes of benzylidene-hydrazone ana-
logues at its active site. Computer-assisted 
drug design (CADD) was used is a useful 
tool for conducting docking simulations, and 
provides important information regarding the 
natures of interactions, favorable bioactive 
conformations, and binding affinities of lig-
ands at active sites of target receptors (Alam 
and Lee, 2016). For these reasons, this tech-
nique is helpful for identifying therapeutic 
lead compounds (Shoichet et al., 2002). 
 
MATERIAL AND METHODS 
Chemistry 
The (E)-N'-Benzylidenebenzohydrazide 
analogues (3a-o) examined in the present 
study were prepared as we previously de-
scribed (Alam and Lee, 2016) from their cor-
responding benzohydrazides (2) as presented 
in Figure 2. The mixture of methyl esters of 
benzoic acid (13.6 g, 0.1 M) or salicylic acid 
(15.2 g, 0.1 M) and hydrazine hydrate 
(12.5 g, 0.25 M) in 100 mL ethanol (roughly) 
were refluxed for 3 h. TLC method was used 
to observe the reaction progress. The ob-
tained solid products were separated and pu-
rified by recrystallization using aqueous eth-
anol. The structures of the synthesized com-
pounds were characterized by comparing the 
previously reported physical and spectral da-
ta. The benzohydrazides (2, 1 mM) so ob-
tained were then refluxed with suitably sub-
stituted benzaldehydes (1 mM) in ethanol for 
1.5-2.5 h. The reaction progress was moni-
tored by TLC. At room temperature, the re-
action mixtures give solid crude products, 
and they were filtered and crystallized using 
ethanol to afford the pure compounds (3a-o) 
(81-96 % yield). 
 
 
 
 
Figure 2: The synthesis of novel (E)-N'-benzylidenebenzohydrazide analogues 3a-o 
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Antibacterial screening  
A previously reported filter paper disc 
diffusion method (Alam and Lee, 2010) was 
used to determine the in vitro antibacterial 
effects of 3a-o against eleven bacterial 
strains. Nutrient agar (NA) media (Difco La-
boratories, Lawrence, KS), a bacterial grow-
ing medium was inoculated with liquid cul-
tures (0.2 mL) of the microorganisms. Discs 
socked with test samples (3a-o) were kept on 
pre-treated agar Petri dishes and incubated 
aerobically at 37 oC (24 h). DMSO and na-
lidixic acid were used as negative and posi-
tive controls, respectively. Bactericidal activ-
ity was defined as inhibitory zones diameters 
in mm. Evaluations were performed in tripli-
cate.  
Minimal inhibitory concentrations (MIC, 
in g/mL) against Klebsiella pneumonia 
(JCM 1662) and Citrobacter freundii (JCM 
1657) were determined using the serial dilu-
tion technique (Alam and Lee, 2010) using 
nutrient broth medium (DIFCO). MIC was 
defined as the lowest concentration of the 
tested compound (in DMSO) that inhibited 
bacterial growth. 
 
Computational analysis 
The molecular geometries of the (E)-N'-
benzylidenebenzohydrazide analogues (3a-o) 
were examined using standard bond length 
and angles using the ChemBio3D ultra Ver. 
14 molecular modeling program (Cam-
bridgeSoft Corporation, Cambridge, MA 
02140, USA). Physicochemical properties 
were calculated using Molinspiration 
Cheminformatics Software (Molinspiration 
Cheminformatics, SK 90026 Slovensky 
Grob, SR). The method used for calculating 
clogP values was developed by Molinspira-
tion (miLogP2.2-2005) derived from the 
group contributions of more than twelve 
thousand drug-like compounds, and the theo-
retical logP and experimental logP values 
were used as a training set for fitting correc- 
 
Table 1: In vitro antimicrobial profiles of (E)-N'-benzylidenebenzohydrazide analogues (3a-o) as de-
termined by growth inhibition zones 
Comp. Gram-positive Gram-negative 
S. a. L. m. B. s. K. p. C. s. C. f. S. e. S. t. E. c. Y. p. P.a. 
3a - - - - - - - - - - - 
3b - - - 13±0.5 - 30±1.5 - - 14±0.5 - - 
3c - - - - - - - - - - - 
3d - - - 14±0.5 14±0.5 25±1.0 - - 14±0.5 - - 
3e 11±1.0 10±1.0 10±1.0 17±1.0 8±0.5 10±1.0  10±1.0 8±1.0 10±0.5 12±1.0 
3f - - - 13±0.5 - - 9±1.0 - 15±0.5 - - 
3g - - - 13±0.5  30±1.0 - - 13±0.5 - 11±1.0 
3h - - - - - - - - - - - 
3i - - - - - 23±0.5 12±1.0 - 15±1.0 - - 
3j - - - - - - 8±1.0 - - - - 
3k - - - 14±0.5 - 22±0.5 - - 11±1.0 - - 
3l 7±0.5 - - 17±0.5 - 9±0.5 7±0.5 - 8±0.5 - - 
3m - - - - - - - - - - - 
3n - - - 16±0.5 - 19±1.5 - - 12±0.5 - - 
3o - - - - - - - - - - - 
NA 24±1.0 8.0±0.5 20±1.0 21±1.0 24±1.0 29±1.5 10±1.0 18±1.0 24±1.0 - 23±1.0 
Inhibitory activities are expressed as diameters (in mm) of observed inhibitory zones. (-), Not active. 
The activities presented are the means  SDs (three experiments). S. a., Staphylococcus aureus (JMC 
2151); L. m, Listeria monocytogenes (ATCC 43256); B. s., Bacillus subtilis (IFO 13719); K. p., 
Klebsiella pneumoniae (JCM 1662); C. s., Cronobacter sakazakii (CARS 2012-J-F); C. f., Citrobacter 
freundii (JCM 1657); S. e., Salmonella enterica (ATCC 10708); S. t., Salmonella enteritidis (ATCC 
13076); E. c., E. coli (CARS 2011-016); Y. p., Yersinia pestis (CARS 2013-027); P.a., Pseudomonas 
aeruginosa (PA01) 
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tion factors. The molecular polar surface are 
as (PSAs) were obtained as sums of frag-
ment contributions (Ertl et al. 2000). Molec-
ular lipophilicity potentials (MLPs) and 
PSAs maps were analyzed using Molinspira-
tion Galaxy 3D Structure Generator (ver. 
2013.02 beta). 
 
Docking studies 
The molecular geometries of compounds 
3c, 3i and 3j were constructed using standard 
bond lengths and angles as mentioned above, 
and energy minimized using the Hartree-
Fock method at 6-31G basis set with R-
Closed-Shell wave function in the Chem-
Bio3D Ultra Ver. 14.0 software (GAMESS 
Interface). The docking studies were per-
formed using crystal structure of E. coli 
FabH-CoA complex retrieved from the Pro-
tein Data Bank (PDB code: 1HNJ). To pre-
pare the receptor for docking studies, co-
crystallized ligand and water molecules were 
removed, while polar hydrogen atoms and 
Kollman-united charges were included to the 
FabH receptor molecule. The necessary pdb 
and pdbqt files of ligands and E. coli FabH 
receptor were prepared using AutoDock 4.2 
software (Morris et al., 2009). The study was 
carried out using the usual docking protocol 
applied for AutoDock Vina in PyRx 0.8 
software (Trott and Olson, 2010) where free 
rotation was allowed through single bonds of 
ligands. The docking results were analyzed 
using Discovery Studio 4.0 (Accelrys, Inc. 
San Diego, CA 92121, USA) and binding 
scores were calculated using iGEMDOCK 
software (Yang and Chen, 2004). 
 
RESULTS AND DISCUSSION 
Antibacterial activities 
Compounds 3a-o were evaluated for their 
in vitro antibacterial activities against three 
Gram-positive bacteria, S. aureus, L. mono-
cytogenes, and B. subtilis, and eight Gram-
negative bacteria K. pneumonia, C. sa-
kazakii, C. freundii, S. enterica, S. enter-
itidis, E. coli, Y. pestis, and P. aeruginosa by 
disc diffusion. As presented in Table 1, 
compound 3e inhibited the growths of all 
bacterial strains except S. enterica, but its ac-
tivity was relatively weak. A half of the test-
ed compounds inhibited G(-)-bacteria K. 
pneumonia, C. freundii, and E. coli, but only 
3e inhibited G(+)-bacteria. Of the com-
pounds tested, 3b and 3g were most effective 
against C. freundii, and had activities similar 
to nalidixic acid (the positive standard). 
Compounds bearing an OH group at the R4-
position (para-position) in the benzylidene 
phenyl ring (e.g., 3b, 3g > 3d > 3i > 3k) bet-
ter inhibited C. freundii. Whereas, com-
pounds with additional OH substitution at 
the meta-position (e.g. 3f) or ortho-positions 
(e.g. 3j) were devoid of activity.  
The minimal inhibitory concentrations 
(MICs) of selected compounds were deter-
mined against K. pneumonia and C. freundii; 
results are summarized in Table 2.  Com-
pounds 3b and 3g had the lowest MIC values 
(18.75 g/mL), followed by 3d, 3i, and 3k 
(37.5 g/mL) against C. freundii, whereas 
compounds 3e, 3l, and 3n had similar MIC 
values (75 g/mL) against K. pneumonia. 
Above results indicate the presence of a po-
lar hydroxyl group at the R4-position (para-
position) favors activity, but that meta posi-
tioned OH groups reduce activity. 
 
Table 2: MIC of some (E)-N'-benzylidene-
benzohydrazide analogues derivatives against 
selected bacterial strains 
Comp.  MIC, g/mL 
K. pneumonia C. freundii 
3b - 18.75 
3d - 37.5 
3e 75 - 
3g - 18.75 
3i - 37.5 
3k  37.5 
3l 75 - 
3n 75 75 
NA 12.5 6.25 
(-), Not measured; MIC, Minimum inhibitory con-
centration; NA, Nalidixic acid. 
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Quantitative-SAR study 
To explain quantitative structure-
antibacterial activity relationships (Q-SAR) 
of the fifteen (E)-N'-benzylidenebenzo-
hydrazide analogues (3a-o), physicochemical 
calculations were conducted using Chem-
Bio3D Pro 12 molecular modeling (Cam-
bridgeSoft Corporation, Cambridge, MA 
02140, USA) and Molinspiration Chem-
informatics software (Molinspiration Chem-
informatics, SK 90026 Slovensky Grob, SR). 
The physicochemical properties of mole-
cules, such as, their lipophilicities and polar 
surface areas (PSAs) play important roles in 
determining biological responses, and are 
commonly used to study the structure-
activity relationships of bioactive molecules 
in medicinal chemistry (Alam et al., 2013; 
Desai et al., 2014). These parameters are 
now well-accepted major experimental and 
theoretical tools for drug design and discov-
ery. The physiochemical parameters of all 
synthesized compounds are listed in Table 3.  
In the present study, a considerable num-
ber of compounds were found to be active 
against K. pneumonia, C. freundii, and E. 
coli. It is well-known that the octanol-water 
partition coefficient (logP) of a molecule de-
pends on its hydrophobicity and polarity, 
which facilitate transit across cellular mem-
branes. Therefore, we examined the correla-
tion between the inhibitory effects of 3a-o 
against K. pneumonia, C. freundii, and E. 
coli and their clogP values. The correlation 
coefficients (r2) between clogP values and 
the inhibitory potencies of active molecules 
against K. pneumonia, C. freundii, and E. 
coli were; 0.86 (n = 8; 3b, 3d-3g, 3k, 3l and 
3n), 0.75 (n = 8; 3b, 3d,3e, 3g, 3i, 3k, 3l, and 
3n), and 0.71 (n = 9; 3b, 3d-3g, 3i, 3k, 3l, 
and 3n), respectively. Although only a rela-
tively small number of compounds were ex-
amined, significant correlations were ob-
served, whereby antibacterial activity in-
creased with clogP against K. pneumonia but 
decreased with clogP against C. freundii and 
E. coli (Figure 3). However, the above corre-
lations should be treated with caution be-
cause the clogP values of 3a, 3c, 3h, 3m, and 
3o fell within the medium range for active 
compounds, but they were in fact inactive. 
Therefore, we compared maps of lipophilici-
ty potential (MLP) and PSA of two selected 
active and inactive compounds (3b and 3g 
 
Table 3: Molinspiration calculations of the molecular properties of (E)-N'-benzylidenebenzohydrazide 
analogues (3a-o) 
Comp. MW (g/mol) clogPa TPSAb OH-NH interactc O-N interactd nrotbe volume 
3a  224.263 3.099 41.462 1 3 3 210.098 
3b 240.262 2.619 61.69 2 4 3 218.116 
3c 254.289 3.155 50.696 1 4 4 235.644 
3d 256.261 2.536 81.918 3 5 3 226.134 
3e 284.315 3.14  59.93 1 5 5 261.19 
3f 256.261 2.13 81.918 3 5 3 226.134 
3g 270.288 2.438 70.924 2 5 4 243.662 
3h 284.315 2.745 59.93 1 5 5 261.19    
3i 300.314 2.454 80.158 2 6 5 269.208 
3j 272.26 2.452 102.146 4 6 3 234.152 
3k 256.261 2.56 81.918 3 5 3 226.134 
3l 256.261 3.528 81.918 3 5 3 226.134 
3m 258.708 3.777 41.462 1 3 3 223.634 
3n 267.332 3.201 44.7 1 4 4 256.004 
3o 252.273 2.841 58.533 1 4 4 229.082 
aCalculated octanol/water partition coefficients; bMolecular polar surface areas; cNumbers of hydrogen-
bond donors; dNumbers of hydrogen-bond acceptors; eNumbers of rotatable bonds 
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vs. 3a and 3c). It was found that lipophilicity 
potentials and the polar surface areas of these 
two pairs of compounds differed (Figure 4). 
These results suggest that the distributions of 
more hydrophilic and polar areas at the para-
position of benzylidene phenyl ring im-
portantly determine activity against specific 
bacterial strains. 
 
Molecular docking studies 
-Ketoacyl-(acyl-carrier-protein) syn-
thase III (FabH), a key bacterial enzyme 
plays a crucial regulatory role in bacterial 
fatty acid synthesis (FAS) by initiating fatty 
acid elongation cycles and providing feed-
back regarding the regulation of FAS, which 
is essentially required for prokaryotic cell 
metabolism, viability, and growth. However, 
the bacterial FAS pathway differs considera-
bly from in man, and bacterial FabH proteins 
are highly conserved at the sequence and 
structural level and show no significant ho-
mology with any human protein. In addition, 
the active site residues of FabH receptor are 
common for Gram-positive and -negative 
bacterial strains (Nie et al., 2005). These fea-
tures make FabH protein a potential thera-
peutic target for the design of novel and 
broad-spectrum antimicrobial agents as se-
lective and nontoxic FabH inhibitors. To 
predict the binding affinities of hydrazone 
Schiff base analogues to FabH, molecular 
docking of (E)-N-benzylidenebenzohydra-
zide analogues having high (3b and 3g)
and low (3n) activity with the active site of 
E. coli FabH receptor was performed. The 
crystal structure of E. coli FabH-CoA com-
plex (Qiu et al., 2001) was retrieved from the 
Protein Data Bank (PDB ID: 1HNJ) and 
compounds 3b, 3g, and 3n were docked at its 
active site using a standard docking protocol. 
In silico docking results are presented in Ta-
ble 4. 
 
Figure 4: Molecular lipophilicity potentials (left) 
and polar surface areas (right) of 3a (A), 3b (B), 
3c (C), and 3g (D) showing areas of lipophilicity 
(blue), intermediate lipophilicity (pink), hydro-
philicity (yellow), intermediate hydrophilicity 
(green), nonpolar (gray/white), and polar (red) 
areas. 
 
 
 
Figure 3: Correlations between inhibition zones (mm) and calculated octanol-water partition coeffi-
cients (clogP) of active (E)-N'-benzylidenebenzohydrazide analogues against (A) K. pneumonia (3b, 
3d-g, 3k, 3l and 3n), (B) C. freundii (3b, 3d, 3e, 3g, 3i, 3k, 3l and 3n), and (C) E. coli (3b, 3d-g, 3i, 3k, 
3l and 3n).  
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Table 4: Docking energies and molecular interactions of the ligand molecules (3b, 3g, and 3n) with E. 
coli FabH receptor 
Entry Binding  
affinity 
(kcal/mol) 
Energy  
contribution 
AverConPair H-bonding 
residues 
(distance, 
Å) 
Hydrophobic  
interactions residues 
vdW H-bond
3b -80.36 -71.29 -9.07 25.72 - Ala111, Cys112, Leu142, 
Ile156, Phe157, Leu189, 
Thr190, Leu191, Leu205, 
Met207,Val212, Phe213, 
Ala246, Ile250, Gly305 
3g -84.33 -71.92 -12.41 26.20 Leu189 
(2.96) 
Leu142, Ile156, Phe157, 
Leu205, Val212, 
Phe213, Asn247, 
Ala246, Ile250, Ser276, 
Gly305, Gly307 
3n -72.22 -72.22 - 23.70 - Ala109, Ala110, Leu142, 
Thr145, Thr190, Leu191, 
Leu205, Ser276, Thr309 
 
 
These studies revealed that all three 
compounds bind to the same active site of 
FabH receptor as endogenous malonyl-CoA 
ligand and other reported hydrazone and 
Schiff base FabH inhibitors (Song et al., 
2014a; Zhou et al., 2013; Shi et al., 2010). 
The binding modes and the different types of 
interactions found for compound 3b (most 
active) and 3n (least active) were compared 
and are shown in Figures 5 and 6, respective-
ly. To measure the affinity of ligands for the 
receptor, we analyzed binding scores for 
compounds 3b, 3g, and 3n by iGEMDOCK 
software (Yang and Chen, 2004); results are 
shown in Table 4. According to docking 
scores, the high activity compounds 3b and 
3g had higher binding affinities with FabH 
receptor than 3n (the binding energies of 3b, 
3g and 3n were -80.36, -84.33, and -72.22 
kcal/mol, respectively). Regarding total 
binding energies, van der Waal contributions 
for 3b and 3g were -71.29 and 71.02 
kcal/mol, respectively, and H-bond contribu-
tions were -9.07 and 12.41 kcal/mol, respec-
tively. While for 3b only van der Waal inter-
actions (-72.22 kcal/mol) contributed to total 
binding energy. In the binding model of 3b 
and E. coli FabH receptor, two -sulfur in-
teractions were observed between the benzo-
yl-phenyl ring and Met207 (3.95 Å) and be-
tween the benzylidene-phenyl ring and 
Cys112 (4.88 Å), together with -alkyl inter-
actions with Ala111(4.22 Å), Leu142 (4.81 
Å), Leu189 (5.07 Å), Leu191 (5.36 Å), 
Leu205 (5.19 Å), Val212(5.47 Å), and 
Ala246 (3.59 Å). However, in the binding 
model of 3g with E. coli FabH receptor, a H-
bond between the carbonyl group of Leu189 
(CHO: 2.96 Å) and methoxy proton, and 
-sulfur and -sigma interactions of Met207 
(3.83 Å) and Ala246 (2.59 Å), respectively 
were observed including -alky interactions 
with Ala111 (3.84 Å), Cys112 (5.32 Å), 
Leu142 (5.07 Å), Leu189 (5.08 Å), and 
Leu191 (5.48 Å). Whereas in the binding 
model of 3n with E. coli FabH receptor, no 
H-bond, -sulfur, or -sigma interactions 
were observed, although -alkyl interactions 
with Ala109 (4.65 Å), Ala111 (4.45 Å), 
Leu189 (4.43 Å), Leu191 (5.34 Å), Leu205 
(5.27 Å), and Gly306 (4.43) involving ben-
zoyl- and benzylidene-phenyl rings were ob-
served. In addition, the following van der 
Waal’s interactions were also observed: be-
tween 3b and Cys112, Ile156, Phe157, 
Thr190, Met207, Phe213, Ile250, and 
Gly305; between 3g and Ile156, Phe157, 
Leu205, Val212, Phe213, Asn247, Ala246, 
Ile250, Ser276, Gly305, and Gly307; and be-
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tween 3n and Ala110, Leu142, Thr145, 
Thr190, Ser276, and Thr309. These results 
indicate compounds 3b, 3g, and 3n bind to 
the same active site of FabH receptor. How-
ever, the most active compounds 3b (Figure 
5) and 3g (figure not shown) attached more 
tightly in the active site of FabH receptor due 
to additional H-bond, -sulfur, -sigma, and 
hydrophobic interactions, which resulted in 
higher binding affinities than compound 3n 
(Figure 6).  
 
Figure 5: (A) E. coli FabH receptor (PDB ID: 1HNJ). (B) HF/6-31G optimized geometry of ligand 3b. 
(C) Docked ligand-receptor complex (the circle shows the ligand binding site) (D) Binding model of 3b 
with E. coli FabH; -alkyl and -sulfur interactions are shown by blue and yellow broken lines, respec-
tively. (E) 2D view of interacting essential amino acid residues at the ligand binding site; The residues 
involved in electrostatic and covalent interactions are shown by purple circles and amino acids in-
volved in van der Waals interactions are shown by green circles. (F) Showing hydrogen bond donor 
(pink) and acceptor (green) surfaces. (G) Showing hydrophobic interactions (brown) surfaces. 
 
Figure 6: (A) E. coli FabH receptor (PDB ID: 1HNJ). (B) HF/6-31G optimized geometry of ligand 3n. 
(C) Docked ligand-receptor complex (the circle indicates the ligand binding site) (D) Binding model of 
compound 3n with E. coli FabH; H-bond and -alkyl interactions are shown by red and blue broken 
lines, respectively. (E) 2D view of interacting essential amino acid residues at the ligand binding site; 
The residues involved in electrostatic and covalent interactions are shown by purple circles and amino 
acids involved in van der Waals interactions are shown by green circles. (F) Showing hydrogen bond 
donor (pink) and acceptor (green) surfaces. (G) Showing hydrophobic interactions (brown) surfaces. 
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CONCLUSION 
The present study reports the antibacteri-
al activities of a series of 15 (E)-N'-
benzylidenebenzohydrazide analogues 
against eleven pathogenic and food-borne 
bacterial strains, of these eleven, three were 
Gram-positive, i.e., S. aureus, L. monocyto-
genes, and B. subtilis, and eight were Gram-
negative, i.e., K. pneumoniae, C. sakazakii, 
C. freundii, S. enterica, S. enteritidis, E. coli, 
Y. pestis, and P. aeruginosa. The compounds 
subjected to antibacterial assay, 3b and 3g, 
which are containing one OH group at the 
para-position of the benzylidene phenyl ring, 
showed lowest MIC values against C. freun-
dii. Physicochemical calculations indicated 
that the antibacterial activities of (E)-N'-
benzylidenebenzohydrazide analogues (3b, 
3d-3g, 3i, 3k, 3l, and 3n) against K. pneu-
monia, C. freundii, and E. coli correlated 
well with calculated logP values. In silico 
screening using molecular docking studies 
were performed to predict the binding affini-
ties and modes of interaction of the most ac-
tive (3b and 3g) and least active (3n) com-
pounds to the active site of E. coli FabH re-
ceptor. Compounds 3b and 3g were found to 
bind effectively to the active site of E. coli 
FabH receptor with high affinity, suggesting 
their potentials as FabH inhibitors. We be-
lieve the above findings can be used to facili-
tate the design and synthesis of novel ben-
zylidenehydrazone analogues as potential an-
tibacterial as FabH inhibitors. 
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